WebOct 1, 2024 · In vivo direct reprogramming for regenerative medicine. The goal of regenerative medicine is to generate cells to ameliorate diseased tissues. The derivation of pluripotent stem cells (PSCs), including ESCs and iPSCs, has provided a promising cell source for regenerative medicine [13, 14]. Because of their self-renewal and differentiation … Web1 day ago · Alcoholic liver injury (ALI) is the leading cause of serious liver disease, whereas current treatments are mostly supportive and unable to metabolize alcohol directly. Here …
Wound, heal thyself Nature Medicine
WebSep 26, 2024 · A NeuroD1 AAV-based gene therapy for functional brain repair after ischemic injury through in vivo astrocyte-to-neuron conversion. Molecular Therapy. 2024. Epub Sept. 6. [2] Guo Z, et al. In vivo direct reprogramming of reactive glial cells into functional neurons after brain injury and in an Alzheimer’s disease model. WebApr 15, 2024 · Advances in Cellular Reprogramming-Based Approaches for Heart Regenerative Repair. Journals. ... Rastaldo, R.; Giachino, C. Direct Reprogramming of Resident Non-Myocyte Cells and Its Potential for In Vivo Cardiac Regeneration. ... Sadia, Roberto Vanni, Marco Lo Iacono, Raffaella Rastaldo, and Claudia Giachino. 2024. "Direct … cree group
Dedifferentiation, transdifferentiation and cell fusion: in vivo ...
WebAug 13, 2024 · In addition to stem cells, dedifferentiation, transdifferentiation and reprogramming events involving tissue-resident somatic cells can also play a central role in endogenous tissue regeneration (Fig. 3). Reprogramming cell identity in vivo. The power of cellular reprogramming and the fact that dedifferentiation seems to promote successful ... WebMar 3, 2024 · There should be consensus about a rigorous means to demonstrate conversion of astrocytes to neurons in vivo. Given the 20-year history of using linage tracing and fate mapping to establish cell conversion, we contend these methods should be the gold standard to claim direct reprogramming in vivo. WebMay 15, 2024 · Cellular reprogramming by activation of OCT4, SOX2, KLF4, and C-MYC (OSKM) transcription factors has recently been discussed as a strategy for regenerating damaged tissues in vivo. The effects of OSKM factors on wound healing in a mouse model have been tested. creehan scriptmed